PHARMADAN A/S: Financial statements 2020
CVR: 26524938
Source: annual report 2020, Danish Business Authority
01/07/2019 – 30/06/2020
PHARMADAN A/S (CVR 26524938) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -8,366 and a net result of DKK -1,618,210 compared with DKK -799,804 the year before. Equity in the 2020 report amounted to DKK 1,016,934. The solvency ratio was 30.6%. The company had 3 employees in the financial year.
- Gross Profit
- DKK -8,366
- Profit/Loss
- DKK -1,618,210
- Equity
- DKK 1,016,934
- Total Assets
- DKK 3,322,592
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -8K | -1.6M | 1M | 3 |
| 2019 | - | 956K | -800K | 2.6M | 3 |
| 2018 | - | 973K | -1.6M | 3.4M | 4 |
| 2017 | - | 585K | -2.6M | -919K | 5 |
| 2016 | - | 1M | -2.7M | 1.7M | 6 |
Official annual report
How creditworthy is PHARMADAN A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of February 13, 2020, Svend Blankholm has left the board of directors of PHARMADAN A/S.
About PHARMADAN A/S
PHARMADAN A/S is a Danish company of the type Aktieselskab based in Kastrup, founded in 2002. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Peter Rørvig. The board consists of Helle Rørvig, Niels Ulrik Heine and Peter Rørvig. The company is owned by H&P Rørvig Holding A/S. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -6,382,654 and a net result of DKK -5,426,641 compared with DKK -5,113,611 the year before. Equity in the 2025 report amounted to DKK -18,955,125.